Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 5 results for "om manchanda"

NABL accreditation to boost diagnostic quality: Dr Lal Pathlabs

Om Manchanda, CEO, Dr Lal Pathlabs says, regulations in the diagnosis space have been limited and there exists scope to extend them to the diagnostics market, which is a highly fragmented. Money Control, 2 months ago
Business Standard India

Diagnostics companies' premium might sustain

Diagnostic major Thyrocare Technologies, listed at a 49 per cent premium over its initial public offering (IPO) price of Rs 446 last Monday, is trading near Rs 630. The trend is similar to the one seen with Dr Lal PathLabs, which listed a few months ...
 Smart Investor1 week ago

Diagnostics companies' premium valuations may sustain

Thyrocare Technologies, the diagnostic major, listed at a 49% premium over its IPO price of Rs 446 last Monday and is now at Rs 630 levels. The trend is similar to the one seen with Dr Lal PathLabs which listed a few months back. Compared to the IPO ...
 Business Standard India1 week ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less